$4.63 -0.16 (-3.34%) TrovaGene Inc - NASDAQ

Sep. 26, 2016 | 04:00 PM
Last Trade: 4.63
Trade Time: Sep 26 04:00 PM Eastern Daylight Time
Change: -0.16 (-3.34%)
Prev Close: 4.79
Open: 4.75
Bid: 4.63
Ask: 4.64
  1. No results found.
  1. Trovagene Announces Agreement with FedMed

    Benzinga | Feb. 1, 2016 | 04:12AM EST
  2. Trovagene Offers Results from Second Large-Scale Trial of Urine-Based HPV Test: Results Compared to Roche's cobas HPV Test

    Benzinga | Sep. 21, 2015 | 08:07AM EST
  3. Trovagene Forms European Subsidiary Trovagene Research Institute

    Benzinga | Sep. 10, 2015 | 04:28AM EST
  4. Why People Lose Money Investing And What You Can Do About It

    GuruFocus | Jul. 29, 2015 | 17:17PM EST
  5. Market Update: Google & Hertz Among Mid-Day Movers, Germany Votes In Favor Of Greece Bailout And More

    Benzinga | Jul. 17, 2015 | 12:16PM EST
  6. Trovagene to Offer Clinical Data on Co.'s Urine-Based Liquid Biopsy Platform at Two Upcoming Conferences

    Benzinga | Jun. 8, 2015 | 08:10AM EST
  7. TrovaGene Falls Sharply; Prices Offering Below Expectations

    Benzinga | Feb. 6, 2015 | 12:57PM EST
  8. Friday Morning Movers: GoPro, Twitter Move In Opposite Directions

    Benzinga | Feb. 6, 2015 | 11:10AM EST
  9. Morning Market Losers

    Benzinga | Feb. 6, 2015 | 09:56AM EST
  10. Morning Market Movers

    Benzinga | Aug. 18, 2014 | 09:45AM EST
  11. Trovagene Secures $15 Million in Debt Financing From Silicon Valley Bank And Oxford Finance

    Benzinga | Jul. 1, 2014 | 08:06AM EST
  12. Trovagene, US Oncology Research Announce Clinical Study Agreement

    Benzinga | Jan. 6, 2014 | 05:40AM EST
  13. Aegis Capital Reiterates on TrovaGene Following In-Line Revenue, Below-Estimates EPS

    Benzinga | Nov. 15, 2013 | 11:09AM EST
  14. UPDATE: Aegis Capital Reiterates on TrovaGene Ahead of 3Q 2013 Earnings Report

    Benzinga | Nov. 13, 2013 | 10:48AM EST
  15. Trovagene Announces Collaboration for Oncogene Mutation Detection Study

    Benzinga | Oct. 16, 2013 | 05:54AM EST
Trading Center